{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:47:56Z","timestamp":1790776076149,"version":"4.1.0"},"reference-count":136,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:00:00Z","timestamp":1518480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>1 million people are predicted to get infected with Lyme disease in the USA in 2018. Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected with Lyme disease in Europe in 2018. In the USA by 2050, 55.7 million people (12% of the population) will have been infected with Lyme disease. In Europe by 2050, 134.9 million people (17% of the population) will have been infected with Lyme disease. Most of these infections will, unfortunately, become chronic. The estimated treatment cost for acute and chronic Lyme disease for 2018 for the USA is somewhere between 4.8 billion USD and 9.6 billion USD and for Europe somewhere between 10.1 billion EUR and 20.1 billion EUR. If governments do not finance IV treatment with antibiotics for chronic Lyme disease, then the estimated government cost for chronic Lyme disease for 2018 for the USA is 10.1 billion USD and in Europe 20.1 billion EUR. If governments in the USA and Europe want to minimize future costs and maximize future revenues, then they should pay for IV antibiotic treatment up to a year even if the estimated cure rate is as low as 25%. The cost for governments of having chronic Lyme patients sick in perpetuity is very large.<\/jats:p>","DOI":"10.3390\/healthcare6010016","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T14:23:48Z","timestamp":1518531828000},"page":"16","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic"],"prefix":"10.3390","volume":"6","author":[{"given":"Marcus","family":"Davidsson","sequence":"first","affiliation":[{"name":"Economist and Independent Researcher, https:\/\/papers.ssrn.com\/sol3\/cf_dev\/AbsByAuth.cfm?per_id=895329"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0306-9877(03)00060-4","article-title":"\u201cLyme disease\u201d: Ancient engine of an unrecognized borreliosis pandemic?","volume":"60","author":"Harvey","year":"2003","journal-title":"Med. Hypotheses"},{"key":"ref_2","unstructured":"Cameron, D.J. (2017, March 21). Proof That Chronic Lyme Disease Exists. Interdiscip. Perspect. Infect. Dis., Available online: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2876246\/."},{"key":"ref_3","unstructured":"ECDC (2017, March 21). Borreliosis. Borre. Available online: http:\/\/ecdc.europa.eu\/en\/healthtopics\/emerging_and_vector-borne_diseases\/tick_borne_diseases\/lyme_disease\/pages\/index.aspx."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/bmj.39363.530961.AD","article-title":"Lyme wars","volume":"335","author":"Tonks","year":"2007","journal-title":"BMJ"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Stricker, R.B., and Johnson, L. (2014). Lyme Disease: Call for a \u201cManhattan Project\u201d to Combat the Epidemic. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003796"},{"key":"ref_6","unstructured":"IDSA (2017, December 08). IDSA: Infectious Diseases Society of America. Available online: http:\/\/www.idsociety.org\/Index.aspx."},{"key":"ref_7","unstructured":"ILADS (2017, December 08). ILADS\u2014End Lyme disease epidemic through education, awareness & physican training. Available online: http:\/\/www.ilads.org\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1874205X01206010140","article-title":"Issues in the diagnosis and treatment of lyme disease","volume":"6","author":"Donta","year":"2012","journal-title":"Open Neurol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.00864-15","article-title":"Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells","volume":"59","author":"Sharma","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1128\/AAC.00883-15","article-title":"Persister Development by Borrelia burgdorferi Populations In Vitro","volume":"59","author":"Caskey","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hodzic, E., Imai, D., Feng, S., and Barthold, S.W. (2014). Resurgence of Persisting Non-Cultivable Borrelia burgdorferi following Antibiotic Treatment in Mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0086907"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.01050-07","article-title":"Persistence of Borrelia burgdorferi following antibiotic treatment in mice","volume":"52","author":"Hodzic","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1128\/AAC.00788-09","article-title":"Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi","volume":"54","author":"Barthold","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/513873","article-title":"Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H\/He mice","volume":"195","author":"Song","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/jcm.35.1.111-116.1997","article-title":"Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment","volume":"35","author":"Straubinger","year":"1997","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vetmic.2005.02.006","article-title":"Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies","volume":"107","author":"Chang","year":"2005","journal-title":"Vet. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Embers, M.E., Barthold, S.W., Borda, J.T., Bowers, L., Doyle, L., Hodzic, E., Jacobs, M.B., Hasenkampf, N.R., Martin, D.S., and Narasimhan, S. (2012). Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection. PLoS ONE, 7.","DOI":"10.1371\/annotation\/4cafed66-fb84-4589-a001-131d9c50aea6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cmi.2015.11.009","article-title":"Isolation of live Borrelia burgdorferi sensu lato spirochaetes from patients with undefined disorders and symptoms not typical for Lyme borreliosis","volume":"22","author":"Rudenko","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF02770837","article-title":"A proposal for the reliable culture of Borrelia burgdorferi from patients with chronic Lyme disease, even from those previously aggressively treated","volume":"26","author":"Phillips","year":"1998","journal-title":"Infection"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/infdis\/158.4.905","article-title":"Cultivation of Borrelia burgdorferi from Joint Fluid Three Months after Treatment of Facial Palsy Due to Lyme Borreliosis","volume":"158","author":"Schmidli","year":"1988","journal-title":"J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/ajcp\/91.1.95","article-title":"Spirochetes in the spleen of a patient with chronic Lyme disease","volume":"91","author":"Cimmino","year":"1989","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.51.5.1489","article-title":"Clinical and serologic follow-up in patients with neuroborreliosis","volume":"51","author":"Treib","year":"1998","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01645543","article-title":"Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis","volume":"17","author":"Weber","year":"1989","journal-title":"Infection"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5694\/j.1326-5377.1998.tb141415.x","article-title":"Culture-positive Lyme borreliosis","volume":"168","author":"Hudson","year":"1998","journal-title":"Med. J. Aust."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1001\/jama.1988.03720180063034","article-title":"Fatal Adult Respiratory Distress Syndrome in a Patient With Lyme Disease","volume":"259","author":"Kirsch","year":"1988","journal-title":"JAMA"},{"key":"ref_27","first-page":"98","article-title":"Long-term results in patients with Lyme arthritis following treatment with ceftriaxone","volume":"24","author":"Mailer","year":"1996","journal-title":"Infection"},{"key":"ref_28","first-page":"454","article-title":"Lyme disease: an infectious and postinfectious syndrome","volume":"21","author":"Asch","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/163.2.311","article-title":"Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis","volume":"163","author":"Pfister","year":"1991","journal-title":"J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2133.2001.04034.x","article-title":"Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus","volume":"144","author":"Breier","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/07853899909115982","article-title":"Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis","volume":"31","author":"Oksi","year":"1999","journal-title":"Ann. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01716077","article-title":"Borrelia burgdorferi DNA in the urine of treated patients with chronic Lyme disease symptoms\u2014A PCR study of 97 cases","volume":"24","author":"Bayer","year":"1996","journal-title":"Infection"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003086-199312000-00038","article-title":"Chronic septic arthritis caused by Borrelia burgdorferi","volume":"297","author":"Battafarano","year":"1993","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/art.1780361118","article-title":"Persistence of Borrelia burgdorferi in ligamentous tissue from a patient with chronic Lyme borreliosis","volume":"36","author":"Hahn","year":"1993","journal-title":"Arthritis Rheumatol."},{"key":"ref_35","first-page":"155","article-title":"First isolation of Borrelia burgdorferi from an iris biopsy","volume":"13","author":"Pfister","year":"1993","journal-title":"J. Clin. Neuroophthalmol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000117104","article-title":"Seronegative chronic relapsing neuroborreliosis","volume":"35","author":"Lawrence","year":"1995","journal-title":"Eur. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14787210.2.4.533","article-title":"Treatment of Lyme disease: A medicolegal assessment","volume":"2","author":"Johnson","year":"2004","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_38","first-page":"2","article-title":"Persistent infection in chronic lyme disease: Does form matter?","volume":"1","author":"Stricker","year":"2013","journal-title":"Res. J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IDR.S15653","article-title":"Lyme disease: The next decade","volume":"4","author":"Stricker","year":"2011","journal-title":"Infect. Drug Resist."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/jcm.29.11.2401-2406.1991","article-title":"Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease","volume":"29","author":"Melchers","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.1287","article-title":"Central and peripheral nervous system infection, immunity, and inflammation in the NHP model of Lyme borreliosis","volume":"50","author":"Pachner","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/jcm.29.5.894-896.1991","article-title":"Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters","volume":"29","author":"Goodman","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The emergence of Lyme disease","volume":"113","author":"Steere","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2147\/IJGM.S44114","article-title":"Review of evidence for immune evasion and persistent infection in Lyme disease","volume":"6","author":"Berndtson","year":"2013","journal-title":"Int. J. Gen. Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Adrion, E.R., Aucott, J., Lemke, K.W., and Weiner, J.P. (2015). Health Care Costs, Utilization and Patterns of Care following Lyme Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116767"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/IDR.S114770","article-title":"Lyme disease: The promise of Big Data, companion diagnostics and precision medicine","volume":"9","author":"Stricker","year":"2016","journal-title":"Infect. Drug Resist."},{"key":"ref_47","unstructured":"IDSA (2017, December 08). IDSA: Updated Guidelines on Diagnosis, Treatment of Lyme Disease. Available online: http:\/\/www.idsociety.org\/Updated_Guidelines_on_Diagnosis_Treatment_of_Lyme_Disease\/."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/NAN.0000000000000195","article-title":"Controversies in Persistent (Chronic) Lyme Disease","volume":"39","author":"Maloney","year":"2016","journal-title":"J. Infus. Nurs."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jme.2008.026526","article-title":"Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process","volume":"35","author":"Johnson","year":"2009","journal-title":"J. Med. Ethics."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1747-5341-5-9","article-title":"The Infectious Diseases Society of America Lyme guidelines: A cautionary tale about the development of clinical practice guidelines","volume":"5","author":"Johnson","year":"2010","journal-title":"Philos. Ethics Hum. Med."},{"key":"ref_51","unstructured":"(2017, December 08). CourtDocumentLymeDisease\u201411 October. Available online: https:\/\/www.courthousenews.com\/wp-content\/uploads\/2017\/11\/LymeDisease.pdf."},{"key":"ref_52","unstructured":"Langford, C. (2017, December 08). Insurers Accused of Conspiring to Deny Lyme Disease Coverage. Available online: https:\/\/www.courthousenews.com\/insurers-accused-conspiring-deny-lyme-disease-coverage\/."},{"key":"ref_53","unstructured":"(2017, December 09). Multiple Chronic Conditions Chartbook. Available online: https:\/\/www.ahrq.gov\/sites\/default\/files\/wysiwyg\/professionals\/prevention-chronic-care\/decision\/mcc\/mccchartbook.pdf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1086\/656690","article-title":"Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America: A Pyrrhic Victory?","volume":"51","author":"Johnson","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_55","unstructured":"The National Academies of Sciences, Engineering, and Medicine (2017, March 17). Standards for Developing Trustworthy Clinical Practice Guidelines: Health and Medicine Division. Available online: http:\/\/www.nationalacademies.org\/hmd\/Reports\/2011\/Clinical-Practice-Guidelines-We-Can-Trust\/Standards.aspx."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archinternmed.2010.482","article-title":"Analysis of Overall Level of Evidence behind Infectious Diseases Society of America Practice Guidelines","volume":"171","author":"Lee","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_57","unstructured":"CDC: Lyme carditis (2017, March 17). What you need to know about Lyme carditis, Available online: https:\/\/www.cdc.gov\/lyme\/signs_symptoms\/lymecarditis.html."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2147\/NDT.S136137","article-title":"Suicide and Lyme and associated diseases","volume":"13","author":"Bransfield","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1586\/14787210.2014.940900","article-title":"Evidence assessments and guideline recommendations in Lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease","volume":"12","author":"Cameron","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_60","unstructured":"ILADS: NGCH (2017, March 18). Evidence assessments and guideline recommendations in Lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease. Available online: https:\/\/www.guideline.gov\/summaries\/summary\/49320."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2147\/IJGM.S23829","article-title":"Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease","volume":"4","author":"Stricker","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"ref_62","unstructured":"CDC, C. (2017, November 25). Treatment, Lyme Disease, Available online: https:\/\/www.cdc.gov\/lyme\/treatment\/index.html."},{"key":"ref_63","unstructured":"CDC PTLDS (2017, June 16). Post-Treatment Lyme Disease Syndrome. Available online: https:\/\/www.cdc.gov\/lyme\/postlds\/index.html."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2155-9627.1000288","article-title":"Lyme Disease: A Bioethical Morass","volume":"7","author":"Jariwala","year":"2016","journal-title":"J. Clin. Res. Bioeth."},{"key":"ref_65","unstructured":"CDC Spider (2017, March 17). CDC_SPIDER_Letter-1.pdf. Available online: https:\/\/usrtk.org\/wp-content\/uploads\/2016\/10\/CDC_SPIDER_Letter-1.pdf."},{"key":"ref_66","unstructured":"(2017, December 07). Office of HIV\/AIDS and Infectious Disease Policy O of the AS for H (OASH), Available online: https:\/\/www.hhs.gov\/ash\/advisory-committees\/tickbornedisease\/about\/21-century-cures-act\/index.html."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1469-0691.2009.02818.x","article-title":"Borrel\u2019s accidental legacy","volume":"15","author":"Wright","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: An epidemic of oligoarticular arthritis in children and adults in three connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jama.1913.04350060018011","article-title":"Idiopathic atrophy of the skin with report of a case","volume":"61","author":"Irvine","year":"1913","journal-title":"JAMA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archderm.1935.01460200040004","article-title":"Acrodermatitis Chronica Atrophicans","volume":"31","author":"Sweitzer","year":"1935","journal-title":"Arch. Derm. Syphilol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1469-0691.1998.tb00381.x","article-title":"Acrodermatitis chronica atrophicans and serologic confirmation of infection due to Borrelia afzelii and\/or Borrelia garinii by immunoblot","volume":"4","author":"Dunand","year":"1998","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"978","DOI":"10.5114\/aoms.2012.30948","article-title":"Lyme disease: Review","volume":"8","author":"Biesiada","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"ref_74","first-page":"226","article-title":"On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenz\u00e6","volume":"10","author":"Fleming","year":"1929","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ja.2008.16","article-title":"Microbial drug discovery: 80 years of progress","volume":"62","author":"Demain","year":"2009","journal-title":"J. Antibiot."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10388","article-title":"Antibiotic resistance is ancient","volume":"477","author":"King","year":"2011","journal-title":"Nature"},{"key":"ref_77","first-page":"572","article-title":"The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer)","volume":"29","author":"Thyresson","year":"1949","journal-title":"Acta Derm. Venereol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ncomms1701","article-title":"New insights into the Tyrolean Iceman\u2019s origin and phenotype as inferred by whole-genome sequencing","volume":"3","author":"Keller","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/08912963.2014.897699","article-title":"Spirochete-like cells in a Dominican amber Ambylomma tick (Arachnida: Ixodidae)","volume":"27","author":"Poinar","year":"2015","journal-title":"Hist. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/37551","article-title":"Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi","volume":"390","author":"Fraser","year":"1997","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Di, L., Pagan, P.E., Packer, D., Martin, C.L., Akther, S., Ramrattan, G., Mongodin, E.F., Fraser, C.M., Schutzer, S.E., and Luft, B.J. (2014). BorreliaBase: A phylogeny-centered browser of Borrelia genomes. BMC Bioinform., 15.","DOI":"10.1186\/1471-2105-15-233"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1099\/mic.0.26944-0","article-title":"Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe","volume":"150","author":"Bunikis","year":"2004","journal-title":"Microbiology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/JCM.01183-08","article-title":"Borrelia carolinensis sp. nov., a New (14th) Member of the Borrelia burgdorferi Sensu Lato Complex from the Southeastern Region of the United States","volume":"47","author":"Rudenko","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0923-2508(92)90116-6","article-title":"Antigenic variation and strain heterogeneity in Borrelia spp","volume":"143","author":"Wilske","year":"1992","journal-title":"Res. Microbiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0923-2508(01)01186-X","article-title":"Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity","volume":"152","author":"Baranton","year":"2001","journal-title":"Res. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00330-07","article-title":"Lyme Arthritis: Current Concepts and a Change in Paradigm","volume":"15","author":"Nardelli","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1874205X01206010094","article-title":"Evolving Perspectives on Lyme Borreliosis in Canada","volume":"6","author":"Sperling","year":"2012","journal-title":"Open Neurol. J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ttbdis.2014.07.009","article-title":"The composition and transmission of microbiome in hard tick, Ixodes persulcatus, during blood meal","volume":"5","author":"Zhang","year":"2014","journal-title":"Ticks Tick Borne Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"11480","DOI":"10.1128\/JVI.01858-14","article-title":"Virome Analysis of Amblyomma americanum, Dermacentor variabilis, and Ixodes scapularis Ticks Reveals Novel Highly Divergent Vertebrate and Invertebrate Viruses","volume":"88","author":"Tokarz","year":"2014","journal-title":"J. Virol."},{"key":"ref_90","unstructured":"Open Eye Pictures (2017, March 17). Excerpts from interview with Willy Burgdorfer. Available online: https:\/\/www.youtube.com\/watch?v=QLIWSkQdCmU&app=desktop."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/BF01713153","article-title":"Transformation of cystic forms of Borrelia burgdorferi to normal, mobile spirochetes","volume":"25","author":"Brorson","year":"1997","journal-title":"Infection"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1099\/mic.0.000027","article-title":"Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms","volume":"161","author":"Herranen","year":"2015","journal-title":"Microbiology"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Sapi, E., Bastian, S.L., Mpoy, C.M., Scott, S., Rattelle, A., Pabbati, N., Poruri, A., Burugu, D., Theophilus, P.A.S., and Pham, T.V. (2012). Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048277"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4236\/ojmm.2014.44029","article-title":"Chronic Lyme Disease: Persistent Clinical Symptoms Related to Immune Evasion, Antibiotic Resistance and Various Defense Mechanisms of Borrelia burgdorferi","volume":"4","author":"Smith","year":"2014","journal-title":"Open J. Med. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0092-8674(00)80206-8","article-title":"Antigenic Variation in Lyme Disease Borreliae by Promiscuous Recombination of VMP-like Sequence Cassettes","volume":"89","author":"Zhang","year":"1997","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1128\/IAI.72.10.5759-5767.2004","article-title":"Borrelia burgdorferi Changes Its Surface Antigenic Expression in Response to Host Immune Responses","volume":"72","author":"Liang","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Coutte, L., Botkin, D.J., Gao, L., and Norris, S.J. (2009). Detailed Analysis of Sequence Changes Occurring during vlsE Antigenic Variation in the Mouse Model of Borrelia burgdorferi Infection. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000293"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Graves, C.J., Ros, V.I.D., Stevenson, B., Sniegowski, P.D., and Brisson, D. (2013). Natural Selection Promotes Antigenic Evolvability. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003766"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Harris, L.M., and Merrick, C.J. (2015). G-Quadruplexes in Pathogens: A Common Route to Virulence Control?. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004562"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.15252\/embr.201540607","article-title":"G4-associated human diseases","volume":"16","author":"Maizels","year":"2015","journal-title":"EMBO Rep."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4155\/fmc.09.172","article-title":"Structural insights into G-quadruplexes: Towards new anticancer drugs","volume":"2","author":"Yang","year":"2010","journal-title":"Future Med. Chem."},{"key":"ref_102","unstructured":"Bay Area Lyme Foundation (2017, December 08). Yuko Nakajima, PhD. Bay Area Lyme Foundation. Available online: http:\/\/www.bayarealyme.org\/our-research\/emerging-leader-award\/yuko-nakajima-phd\/."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1111\/1462-2920.13897","article-title":"Sleeper cells: The stringent response and persistence in the Borreliella (Borrelia) burgdorferi enzootic cycle","volume":"19","author":"Cabello","year":"2017","journal-title":"Environ. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1699-0463.1999.tb01594.x","article-title":"An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole","volume":"107","author":"Brorson","year":"1999","journal-title":"APMIS"},{"key":"ref_105","first-page":"139","article-title":"An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole","volume":"7","author":"Brorson","year":"2004","journal-title":"Int. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10123-002-0055-2","article-title":"An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to hydroxychloroquine","volume":"5","author":"Brorson","year":"2002","journal-title":"Int. Microbiol."},{"key":"ref_107","first-page":"PI136","article-title":"Macrolide therapy of chronic Lyme Disease","volume":"9","author":"Donta","year":"2003","journal-title":"Med. Sci. Monit."},{"key":"ref_108","first-page":"322","article-title":"Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening","volume":"7","author":"Marinescu","year":"2014","journal-title":"Rev. J. Med. Life"},{"key":"ref_109","first-page":"97","article-title":"Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi","volume":"4","author":"Sapi","year":"2011","journal-title":"Infect. Drug Resist."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"ILADS webpage (2004). Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti-Infect. Ther., 2, S1\u2013S13.","DOI":"10.1586\/14789072.2.1.S1"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","article-title":"Lyme neuroborreliosis. Peripheral nervous system manifestations","volume":"113","author":"Halperin","year":"1990","journal-title":"Brain"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199011223232102","article-title":"Chronic neurologic manifestations of Lyme disease","volume":"323","author":"Logigian","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1212\/WNL.37.11.1700","article-title":"Lyme disease: Cause of a treatable peripheral neuropathy","volume":"37","author":"Halperin","year":"1987","journal-title":"Neurology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mehy.2008.09.030","article-title":"Clinical trials validate the severity of persistent Lyme disease symptoms","volume":"2","author":"Cameron","year":"2009","journal-title":"Med. Hypotheses"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/518853","article-title":"Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with lyme disease","volume":"5","author":"Stricker","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_116","first-page":"89","article-title":"Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial","volume":"99","author":"Cameron","year":"2008","journal-title":"Minerva Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1086\/516171","article-title":"Tetracycline therapy for chronic Lyme disease","volume":"25","author":"Donta","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1212\/WNL.42.2.303","article-title":"Clinical and electrophysiologic findings in chronic neuropathy of Lyme disease","volume":"42","author":"Logigian","year":"1992","journal-title":"Neurology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S1499","DOI":"10.1093\/clinids\/11.Supplement_6.S1499","article-title":"Abnormalities of the nervous system in Lyme disease: response to antimicrobial therapy","volume":"11","author":"Halperin","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cct.2012.08.009","article-title":"Antibiotic retreatment of Lyme disease in patients with persistent symptoms: A biostatistical review of randomized, placebo-controlled, clinical trials","volume":"33","author":"Delong","year":"2012","journal-title":"Contemp. Clin. Trials"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10096-011-1157-6","article-title":"Large differences between test strategies for the detection of anti-Borrelia antibodies are revealed by comparing eight ELISAs and five immunoblots","volume":"30","author":"Ang","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_122","first-page":"419","article-title":"Lyme disease diagnosis and treatment: Lessons from the AIDS epidemic","volume":"101","author":"Stricker","year":"2010","journal-title":"Minerva Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF02771839","article-title":"In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium","volume":"26","author":"Brorson","year":"1998","journal-title":"Infection"},{"key":"ref_124","unstructured":"Schoonjans, F. (2017, March 18). Diagnostic test evaluation calculator. Available online: https:\/\/www.medcalc.org\/calc\/diagnostic_test.php."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Middelveen, M.J., Burke, J., Sapi, E., Bandoski, C., Filush, K.R., Wang, Y., Franco, A., Timmaraju, A., Schlinger, H.A., and Mayne, P.J. (2017, March 18). F1000Research. Available online: http:\/\/f1000research.com\/articles\/3-309\/v3.","DOI":"10.12688\/f1000research.5778.2"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.antiviral.2014.05.016","article-title":"The ecology of ticks and epidemiology of tick-borne viral diseases","volume":"108","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_127","unstructured":"(2017, March 19). CDC HIV. Available online: https:\/\/www.cdc.gov\/nchhstp\/newsroom\/docs\/CDC_TransmissionRates_FactSheet.pdf."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme Disease Testing by Large Commercial Laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","unstructured":"Hinckley, A.F. (2017, September 10). Supplementary data to Lyme disease testing by large commercial laboratories in the United States. Available online: https:\/\/oup.silverchair-cdn.com\/oup\/backfile\/Content_public\/Journal\/cid\/59\/5\/10.1093_cid_ciu397\/1\/ciu397_Supplementary_Data.zip?Expires=1512837512&Signature=RffWKdBkXiX6hlSWu5IqE3G~VQomUI713OMhRVsa4WxGUvauJy1rq9gAAV3EYqBbojqfeBkvo~eqvXJWk5TDNrdI0QFZ~3q5m09iW716itJ20NQgnfw~7FibPdq6OMtTE19GPgdHP~X5cbWjBvJ4VRiXB~xYwvaJg1dnfY3NOVsNRai1i4sAgFgvtCnILZ4dWh6mt-SmjaR6nEI-Q7IfNevJjePqymCPw46IZxD7xi91E13iwH~1KDlct06nC0z87LPcpsfbZjklnEVUmWo5ad1RYi7TxLwfTmfdlqBPWuJTC6ZflhxqwJtlpyEO4VkdwGLvsbo1dJ5FS2GmoOqkjw__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q."},{"key":"ref_130","unstructured":"Seemann, E. (2017, October 17). Are Social Security Disability Benefits Taxable?. Available online: https:\/\/www.labovick.com\/2015\/02\/13\/social-security-disability-benefits-taxable\/."},{"key":"ref_131","unstructured":"Sweden\u2019s government tax agency (2017, September 10). Skatteregler f\u00f6r privatpersoner SKV 330 utg\u00e5va 38. Available online: https:\/\/www.skatteverket.se\/download\/18.57cadbbd15a3688ff448d20\/1488271841075\/skatteregler-for-privatpersoner-skv330-utgava38.pdf."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.7717\/peerj.322","article-title":"Severity of chronic Lyme disease compared to other chronic conditions: A quality of life survey","volume":"2","author":"Johnson","year":"2014","journal-title":"PeerJ"},{"key":"ref_133","unstructured":"OECD Statistics (2017, October 17). OECD. Available online: http:\/\/stats.oecd.org\/index.aspx?r=659459&errocode=403&lastaction=login_submit."},{"key":"ref_134","unstructured":"TKPMG (2017, October 17). Individual income tax rates table. Available online: https:\/\/home.kpmg.com\/xx\/en\/home\/services\/tax\/tax-tools-and-resources\/tax-rates-online\/individual-income-tax-rates-table.html."},{"key":"ref_135","unstructured":"Disability Secrets, B. (2017, March 18). How Much in Social Security Disability Benefits Can You Get? Disability Secrets. Available online: http:\/\/www.disabilitysecrets.com\/how-much-in-ssd.html."},{"key":"ref_136","unstructured":"Swedish government (2017, October 17). Sjukers\u00e4ttning vid Sjukdom. Available online: https:\/\/www.forsakringskassan.se\/privatpers\/sjuk\/sjuk_minst_1_ar\/sjukersattning."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/6\/1\/16\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:55:01Z","timestamp":1760194501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/6\/1\/16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,3]]}},"alternative-id":["healthcare6010016"],"URL":"https:\/\/doi.org\/10.3390\/healthcare6010016","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]}}}